Clinical Infectious Diseases · 2008 · 308 citations · 20 references
Health ProfessionsPharmacologyPharmacotherapyAntimicrobial PharmacotherapyDiabetic Foot CarePodiatric DermatologyAntibiotic Therapy For Foot InfectionsDiabetic Foot DiseaseDiabetic Foot Ulcer CareDiabetic Foot UlcerationFoot InfectionsInfection ManagementDiabetic Foot DisordersFluoroquinolone AntibioticsInfected Foot UlcersInfected UlcersSystemic Antimicrobial TherapyTopical Antimicrobial AgentsTopical Antimicrobial ApplicationTopical Antimicrobial Preparations
BACKGROUND: Topical antimicrobial therapy of infected diabetic foot ulcers can focus on the wound and avoid the adverse effects of systemic anti-infective agents. We compared the efficacy of outpatient treatment using an investigational topical antimicrobial peptide, pexiganan acetate cream, with the efficacy of systemic therapy using an oral fluoroquinolone antibiotic, ofloxacin, for mildly infected diabetic foot ulcers. METHODS: In 2 consecutive, double-blind, controlled trials (study 303 and study 304), we randomized diabetic patients with a mildly infected diabetic foot ulcer to receive the active topical agent or active oral antibiotic, plus a respective inactive placebo. The primary outcome of interest was clinical cure or improvement of the infection. Secondary outcomes included eradication of wound pathogens and wound healing, which was documented by a semiquantitative scoring system. RESULTS: Overall, 835 patients were randomized; those in each treatment arm were similar with regard to demographic and clinical characteristics. Although study 303 failed to demonstrate equivalence, study 304 and the combined data for the 2 trials demonstrated equivalent results (within the 95% confidence interval) for topical pexiganan and oral ofloxacin in clinical improvement rates (85%-90%), overall microbiological eradication rates (42%-47%), and wound healing rates. The incidence of worsening cellulitis (2%-4%) and amputation (2%-3%) did not differ significantly between treatment arms. Bacterial resistance to ofloxacin emerged in some patients who received ofloxacin, but no significant resistance to pexiganan emerged among patients who received pexiganan. CONCLUSIONS: Topical pexiganan might be an effective alternative to oral antibiotic therapy in treating diabetic patients with a mildly infected foot ulcer, and might reduce the risk of selecting antimicrobial-resistant bacteria.
20
Antimicrobial peptides of multicellular organisms
Michael Zasloff · Nature · 2002 · 8.4K citations
Pathways to Diabetic Limb Amputation: Basis for Prevention
Roger E. Pecoraro, Gayle E. Reiber, Ernest M. Burgess · Diabetes Care · 1990 · 1.6K citations
Medicine, Internal Medicine, Surgery +13
Diagnosis and Treatment of Diabetic Foot Infections
Benjamin A. Lipsky, Anthony R. Berendt, H. Gunner Deery et al. · Clinical Infectious Diseases · 2004 · 1.1K citations · Full text
Risk Factors for Foot Infections in Individuals With Diabetes
Lawrence A. Lavery, David G. Armstrong, Robert P. Wunderlich et al. · Diabetes Care · 2006 · 771 citations · Full text